Medicine & Health

Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.

A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Researchers at WashU Medicine have identified a possible way to make brain cancer cells vulnerable to different types of immunotherapy, in hopes of finding new treatments for one of the most deadly cancers.

A new analysis led by WashU Medicine researchers has revealed detailed 3D maps of the internal structures of multiple tumor types. These maps could lead to new approaches to therapy.

Enrollment in Medicaid was associated with higher risk of death from a central nervous system (CNS) tumor, with an almost two-fold higher risk for young CNS tumor patients enrolled at diagnosis, finds a study from the Brown School at Washington University.

The American Cancer Society and venture capital firm Yosemite have selected five WashU faculty to receive the inaugural ACS-Yosemite research grants.

Kelly L. Bolton, MD, PhD (right), and Maggie Mullen, MD, both at WashU Medicine, have received grants from the Damon Runyon Cancer Research Foundation for their respective patient-oriented cancer research. 

Two professors of radiation oncology at Washington University School of Medicine in St. Louis — Clifford G. Robinson, MD, and Julie K. Schwarz, MD, PhD — have been named fellows of the American Society for Radiation Oncology.

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, soon will open a newly constructed nine-story, 657,250-square-foot building on the Washington University Medical Campus. The state-of-the-art building will be dedicated exclusively to outpatient cancer care and will welcome its first patients Sept. 30.

Washington University School of Medicine faculty members Mark Rutherford and Yang E. Li have won grants from St. Baldrick’s Foundation to study pediatric cancers.